1. Executive Summary 2. Introduction 2.1 Causes of Peripheral Artery Disease 2.1.1 Risk Factors for Peripheral Artery Disease 2.2 Symptoms of Peripheral Artery Disease 2.3 Diagnosis of Peripheral Artery Disease 2.4 Treatment of Peripheral Artery Disease 2.4.1 Percutaneous Transluminal Angioplasty (PTA) 2.4.2 Stents 2.4.3 Arterial Bypass 2.4.4 Atherectomy 2.4.5 Amputation 3. Global Peripheral Artery Disease Market Analysis 3.1 Global Peripheral Artery Disease Market: An Analysis 3.1.1 Global Peripheral Artery Disease Market by Value 3.1.2 Global Peripheral Artery Disease Market by Number of People Affected 3.1.3 Global Peripheral Artery Disease Market by Prevalence 3.1.4 Global Peripheral Artery Disease Market by Treatment Mix 3.1.5 Global Peripheral Artery Disease Market Share by Players 3.2 Global PAD Atherectomy Market: Sizing and Growth 3.2.1 Global PAD Atherectomy Market by Value 3.2.2 Global PAD Atherectomy Market Share by Players 4. Global Peripheral Artery Disease Device Market: An Analysis 4.1 Global Peripheral Artery Disease Device Market: Sizing and Growth 4.1.1 Global PAD Device Market by Value 4.1.2 Global PAD Device Market by Products 4.2 Global PAD Angioplasty Balloon Market: Sizing and Growth 4.2.1 Global PAD Angioplasty Market by Type 4.2.2 Global PAD Drug Coated Balloon (DCB) Market 4.3 Global PAD Stent Market: Sizing and Growth 4.3.1 Global PAD Stent Market Share by Players 4.3.2 Drug Eluted Stents (DES) Pricing Trends by Geography 4.3.3 Drug Eluted Stents (DES) Estimated Volume Trends by Geography 5. Regional/Country Analysis 5.1 US Peripheral Artery Disease Market: An Analysis 5.1.1 US PAD Market by Volume 5.1.2 US PAD Market by Treatment Mix 5.1.3 US PAD Atherectomy Market 5.1.4 US PAD Drug Coated Balloon (DCB) Market 6. Market Dynamics 6.1 Growth Drivers 6.1.1 PAD Increases with Age 6.1.2 Rising Global Healthcare Expenditure 6.1.3 Growing Cases for Obesity 6.1.4 Increase in Global Diabetic Population 6.1.5 Favorable Reimbursement Rates 6.2 Challenges 6.2.1 Limitation of Balloon/Stents 6.2.2 In-Stent Restenosis 6.2.3 Inappropriate Diagnostics 6.3 Market Trends 6.3.1 Shift from bypass surgeries to less invasive treatments 6.3.2 Drug Eluting Balloons 6.3.3 Imaging in Endovascular Treatment 7. Competitive Landscape 8. Company Profiles 8.1 Johnson & Johnson (Cordis Corporation) 8.1.1 Business Overview 8.1.2 Financial Overview 8.1.3 Business Strategy 8.2 Medtronic Inc. 8.2.1 Business Overview 8.2.2 Financial Overview 8.2.3 Business Strategy 8.3 Stryker Corporation 8.3.1 Business Overview 8.3.2 Financial Overview 8.3.3 Business Strategy Table of Figures Figure 1: Risk Factors for Peripheral Artery Disease Figure 2: Diagnosis of Peripheral Artery Disease Figure 3: Peripheral Artery Disease by Treatment Figure 4: Global Peripheral Artery Disease Market by Value; 2006-2014 (US$ Billion) Figure 5: Global Peripheral Artery Disease Market by Value; 2015-2020 (US$ Billion) Figure 6: Global Peripheral Artery Disease Market by Number of People Affected; 2010-2014 (Million) Figure7: Global Peripheral Artery Disease Market by Number of People Affected; 2015-2020 (Million) Figure 8: Global Peripheral Artery Disease Market by Prevalence; 2014 Figure 9: Global Peripheral Artery Disease Market by Treatment Mix; 2014 Figure 10: Global Peripheral Artery Disease Market Share by Players; 2014 Figure 11: Global PAD Atherectomy Market by Value; 2012-2020 (US$ Million) Figure 12: Global PAD Atherectomy Market Share by Players; 2014 Figure 13: Global PAD Device Market by Value; 2014-2020 (US$ Billion) Figure 14: Global PAD Device Market by Products; 2014 Figure 15: Global PAD Angioplasty Market by Type; 2014 (US$ Million) Figure 16: Global PAD Drug Coated Balloon Market by Value; 2014-2020 (US$ Million) Figure 17: Global PAD Drug Coated Balloon Market by Players; 2020 Figure 18: Global PAD Stent Market Share by Players; 2014 Figure 19: Drug Eluted Stents (DES) Pricing Trends by Geography; 2010-2014 (US$) Figure 20: Drug Eluted Stents (DES) Estimated Volume Trends by Geography; 2010-2014 (Million Units) Figure 21: US PAD Market by Volume; 2012-2015 (Million) Figure 22: US PAD Market by Diagnosed Cases and PAD Interventions; 2012-2015 (Million) Figure 23: US PAD Market by Number of Atherectomy Procedures; 2012-2015 (Thousand) Figure 24: US PAD Market by Treatment Mix; 2014 Figure 25: US PAD Atherectomy Market by Value; 2012-2015 (US$ Million) Figure 26: US PAD Atherectomy Market by Value; 2016-2020 (US$ Million) Figure 27: US PAD Atherectomy Market by Players; 2014 Figure 28: US PAD Drug Coated Balloon (DCB) Market by Value; 2015-2020 (US$ Million) Figure 29: US PAD Drug Coated Balloon (DCB) Market by Players; 2015-2017 Figure 30: PAD Prevalence by Age Group; 2014 Figure 31: World Population; 2009-2014 (Billion) Figure 32: Global Healthcare Expenditure; 1995-2022 (US$ Trillion) Figure 33: Global Obese Population; 2009-2014 (Million) Figure 34: Global Diabetic Population; 2009-2014 (Million) Figure 35: PAD Reimbursement Rates; 2013-2014 (Percentage Change) Figure 36: Market Share of Major Players in Global Peripheral Artery Disease Market; 2010-2014 Figure 37: Johnson & Johnson Revenue; 2010-2014 (US$ Billion) Figure 38: Johnson & Johnson Revenue; 2014 Figure 39: Johnson & Johnson Revenue by Region; 2014 Figure 40: Medtronic Revenue; 2011-2014 (US$ Billion) Figure 41: Medtronic Revenue by Segments; 2015 Figure 42: Medtronic Revenue by Region; 2015 Figure 43: Stryker Revenue; 2010-2014 (US$ Billion) Figure 44: Stryker Revenue by Segments; 2014 Figure 45: Stryker Revenue by Region; 2014 Table 1: US Atherectomy Market Overview by Players Table 2: Financial Comparison of Major Players in Global Peripheral Artery Disease Market; 2014 (US$ Billion) Table 3: US Peripheral Artery Disease Market by Players’ Product Portfolio